SK bioscience Co.,Ltd. (KRX: 302440)
South Korea
· Delayed Price · Currency is KRW
44,850
+150 (0.34%)
Nov 18, 2024, 3:30 PM KST
SK bioscience Co.,Ltd. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 15, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,513,876 | 5,528,451 | 5,643,627 | 17,212,500 |
| Market Cap Growth | -33.80% | -2.04% | -67.21% | - |
| Enterprise Value | 2,379,090 | 4,326,779 | 4,104,200 | - |
| Last Close Price | 44850.00 | 72000.00 | 73500.00 | 225000.00 |
| PE Ratio | 125.80 | 248.28 | 46.23 | 46.78 |
| Forward PE | - | - | 24.69 | 23.37 |
| PS Ratio | 9.27 | 14.96 | 12.36 | 18.53 |
| PB Ratio | 1.98 | 3.24 | 3.24 | 10.75 |
| P/TBV Ratio | 2.34 | 3.27 | 3.25 | 10.78 |
| P/FCF Ratio | 139.74 | - | - | 34.87 |
| P/OCF Ratio | 29.90 | 188.39 | - | 32.08 |
| EV/Sales Ratio | 6.40 | 11.71 | 8.99 | - |
| EV/EBITDA Ratio | 58.54 | 189.96 | 28.85 | - |
| EV/EBIT Ratio | 646.46 | - | 35.68 | - |
| Debt / Equity Ratio | 0.06 | 0.01 | 0.07 | 0.07 |
| Debt / EBITDA Ratio | 2.45 | 0.90 | 0.80 | 0.22 |
| Debt / FCF Ratio | 3.96 | - | - | 0.22 |
| Asset Turnover | 0.19 | 0.19 | 0.21 | - |
| Inventory Turnover | 1.18 | 1.70 | 1.35 | - |
| Quick Ratio | 9.15 | 9.56 | 4.13 | 3.68 |
| Current Ratio | 10.12 | 10.20 | 4.69 | 4.00 |
| Return on Equity (ROE) | 1.59% | 1.30% | 7.33% | - |
| Return on Assets (ROA) | 0.14% | -0.38% | 3.38% | - |
| Return on Capital (ROIC) | 0.16% | -0.42% | 4.04% | - |
| Earnings Yield | 0.79% | 0.40% | 2.17% | 2.06% |
| FCF Yield | 0.72% | -0.26% | -3.51% | 2.87% |
| Buyback Yield / Dilution | -0.17% | 0.01% | -4.32% | - |
| Total Shareholder Return | -0.17% | 0.01% | -4.32% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.